Cannabinoids as future treatment for epilepsy.

The authors convey their concerns about cannabinoids as future treatment for epilepsy. The authors said scientific proof that supports the efficacy and safety of adjuvant cannabidiol (CBD) use for specific pediatric seizures is accumulating. It is said that epilepsy affects one of 23 persons of the general population. Public interest was said to be fueled by anecdotal reports of children with treatment-refractory epilepsy who had response with CBD use.